Ohio police departments are using up their supplies of the anti-overdose drug naloxone at a faster rate than normal to keep up with the state's high numbers of drug overdoses, reports KWQC.
Supply Chain
Sarepta Therapeutics' newly approved Duchenne muscular dystrophy drugeteplirsen will cost about $300,000 a year, depending on patient weight, according to STAT.
The Food and Drug Administration recently approved KVK Tech's drug Lomaira.
Thirteen top drug companies joined efforts to fight antimicrobial resistance by vowing to reduce pollution emitted from antibiotic factories, according to a statement released on Tuesday.
Emma Walmsley will replace Andrew Witty as CEO of Britain-based GlaxoSmithKline when he retires on March 31, making her the first women to manage a leading global drug company, according to Reuters.
Advertisement
West Virginia Attorney General Patrick Morrisey (R) launched an investigation on Mylan over potential antitrust violations and state Medicaid fraud, reported USA Today.
Blackstone, a private equity company based in New York City, will purchase Irvine, Calif.-based LBA Realty's portfolio of logistics centers for $1.5 billion, according to The Wall Street Journal.
Cambridge, Mass.-based Sarepta Therapeutics earned tentative approval from the Food and Drug Administration for its Duchenne's muscular dystrophy drug eteplirsen, according to The New York Times.
A recent report from the Government Accountability Office found that while Medicare Part D generic drug prices decreased overall from 2010 to 2015, many showed exorbitant price hikes.
Joe Kaeser, CEO of Germany-based Siemens, believes geopolitical turbulence may prevent customers from spending money on projects, limiting the amount of orders and revenue the engineering company brings in, reported Bloomberg.